Skip navigation
CBI
The Leader in Conferences for the Pharmaceutical Industry
Geno Germano
Bridget Bourgeois
Bert Weinstein
Kip Ebel
Richard S. Bowles, III Ph.D
Kevin L. Espinoza
Sally J. Rockey Ph.D.
Brian Elsbernd
Heather McCollum
Dennis Barnes Esq.
Mark Linver
Todd LaMastres
Augusta Monica Jonhart
Kathleen Meriwether
Rob Arreola
Paul J. Silver
Mark P. Graves J.D., MBA
Wendy Tsuei
Paulette J. Morgan
John Oroho
Jon Wilkenfeld
Eileen E. Erdos
Dave Vance
Thomas A. Gregory
Debra L. Bromson
Clarissa Crain
Mark DeWyngaert Ph.D.
Kris Curry
Jim Zuffoletti
David Sandoval Esq.
Jill Furman
Vincent Walden
Heidi L. Straub
Sue Seferian
Doug Lankler
Michael Shaw
Jeffrey K. Francer
Jeremy Perisho
Jean Frydman
Michael Bell Esq.
Andy Bender
Judy Fox
Wendy Goldstein
Todd J. Kerr CPA
Marian Lee
Ted Acosta J.D.
John Krayniak
Dan Koerner
Danielle Bacco
Saul B. Helman M.D.
Seth Lundy
Tracy Mastro
John Rah
Kurt Conger
James D. Kole
Jonathan Provoost
Jack Mitchell
Erik Eglite
Sarah Giesting
Garineh Dovletian

PCC 2012 – CBI’s 9th Annual Pharmaceutical Compliance Congress

Thousands of Executives have benefited from CBI’s Flagship Compliance Congress!

January 24-25, 2012
  • Washington, District of Columbia

The government continues to pursue investigations and announce large-dollar settlements for healthcare fraud enforcement. At the same time, compliance professionals are continually working to better their internal processes, oversight and strategy to enhance corporate compliance programs and instill a culture of compliance at their organizations.  Best practices are being developed each day and CBI is pleased to organize industry’s preferred congress as the meeting place for senior-level executives to share those efforts and successes.

PCC 2012 features 17 Chief Compliance Officers, including Conference Chairman and CCO of Pfizer, Doug Lankler.  More than 40 industry compliance, legal and regulatory peers unite with leading consulting, legal and technology experts to create a knowledgeable speaking faculty ready to engage the audience in interactive and insightful programming.

Pfizer Specialty Care and Oncology President and GM, Geno Germano, joins representatives from DDMAC, the NIH, the U.S. Senate, as well as state and federal enforcement agencies for a jam-packed morning of Keynote Addresses.

Customize Your Congress! Content Covers All Aspects of Corporate Compliance Strategy and Processes including:

  • Fraud and Abuse
  • Global Anti-Corruption
  • Promotional Compliance
  • Off-Label Risk Areas
  • Sunshine Requirements
  • Aggregate Spend Processes
  • Field Monitoring and Investigative Practices
  • Effective Communication and Training Programs
  • Clinical Investigator and CRO Compliance Oversight
  • Social Media Regulatory Issues
  • and much more!

Register now for the 2012 Compliance Event of the Year!

 


 

About Our Silver Sponsor Epstein Becker Green

Epstein Becker Green is uncompromising in its pursuit of legal excellence and client service in its areas of practice: Health Care and Life Sciences, Labor and Employment, Litigation, Corporate Services, and Employee Benefits. The Firm was founded to serve the health care industry and has been at the forefront of health care legal developments since 1973. The Firm is also proud to be a trusted advisor to clients in the financial services and hospitality industries, among others, representing entities from startups to Fortune 100 companies. Our commitment to these practices and industries reflects the founders' belief in focused proficiency paired with seasoned experience. EBG's national practices regularly share and access each other's knowledge and resources to provide clients with tailored solutions to their legal and business issues. Understanding the complex evolution and critical trends within these areas enables EBG practitioners to provide clients with focused insight and deliver high-quality service and results.